Gerhard Ehninger

DKMS Americas is a bone marrow donor center. The firm develops, organizes and operates bone marrow drives with the intention of saving the lives of patients. The company was founded in 2004 by Katharina Harf and is headquartered in New York, NY.

Universitätsklinikum Gießen & Marburg GmbH operates as a university hospital. It provides health services to the citizens of nearby cities and opportunities for medical students to practice their professions. The hospital was founded in 2005 and is headquartered in Gießsen, Germany.

Cellex Cell Professionals GmbH provides biological research and development for bone marrow and stem cell donations. The private company is based in Cologne, Germany. and has subsidiaries in Germany. The CEOs are Gerhard Ehninger, Carla Kreissig, Jochen Nething. The German company was founded in 2001.

Part of AvenCell Therapeutics, Inc., GEMoaB Monoclonals GmbH is a German company that manufactures biopharmaceutical products. The private company is based in Dresden, Germany. The company was founded in 2014 by Gerhard Ehninger. GEMoaB Monoclonals was acquired by AvenCell Therapeutics, Inc. from Cellex Cell Professionals GmbH on March 30, 2022.

AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021.

DKMS gemeinnützige GmbH is a non-profit organization based in Tubingen, Germany. DKMS is dedicated to fighting various types of blood cancer through stem cell donations. The German company's mission is to inform people about the process of donating stem cells and encourage them to become part of the DKMS family. The non-profit company was founded in 2004 by Peter Harf, and the CEOs are Sirko Geist, Elke Neujahr, Alexander Schmidt.